Thornton & Ross to acquire established GSK Consumer Health brands

  • 07/06/2019
  • Press Release

Huddersfield, June 07, 2019 – Thornton & Ross has expanded its Consumer Health business with a contract to acquire four UK skin care brands, as well as a paediatric cough remedy, from GlaxoSmithKline. Completion of the deal is expected to occur by August 2019.

The brands being acquired from GSK, all of which have the opportunity for revitalisation and accelerated growth, are: Oilatum, an emollient brand currently focused in the paediatric market; heritage antiseptic brand Savlon, which has been a medicine cabinet essential for generations; Eurax, a topical itch relief cream; Polytar, a coal-tar based dandruff shampoo that is a medical treatment for scalp conditions including psoriasis; and Tixylix, a range of paediatric cough liquids.

Head and Executive Vice President of Thornton & Ross, Roger Scarlett-Smith says: “These acquisitions demonstrate our ambition to be the leading company in Consumer Health. Our existing expertise in skincare and cough remedies puts us in a strong position to support and grow these acquisitions. We look forward to giving these brands a new home and a bright future.”